These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 11252215

  • 1. Treatment of the patient with deep vein thrombosis.
    Weismantel D.
    J Fam Pract; 2001 Mar; 50(3):249-56. PubMed ID: 11252215
    [No Abstract] [Full Text] [Related]

  • 2. Secondary prophylaxis with low molecular weight heparin: the dose?
    Horne MK.
    Thromb Haemost; 2001 Oct; 86(4):1129. PubMed ID: 11686343
    [No Abstract] [Full Text] [Related]

  • 3. Management of deep vein thrombosis in cancer patients.
    Jahanzeb M.
    J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S50-3. PubMed ID: 16280114
    [No Abstract] [Full Text] [Related]

  • 4. Deep vein thrombosis and anticoagulant therapy.
    Sullano MA, Ortiz EJ.
    Nurs Clin North Am; 2001 Dec; 36(4):645-63, v. PubMed ID: 11726345
    [Abstract] [Full Text] [Related]

  • 5. When can the patient with deep venous thrombosis begin to ambulate?
    Aldrich D, Hunt DP.
    Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299
    [No Abstract] [Full Text] [Related]

  • 6. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
    Tran H, McRae S, Ginsberg J.
    Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997
    [Abstract] [Full Text] [Related]

  • 7. Management of deep vein thrombosis.
    Chong BH.
    Aust Fam Physician; 2001 Mar; 30(3):235-40. PubMed ID: 11301761
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Deep venous thrombosis--treatment].
    Fries R, Böhm M.
    Dtsch Med Wochenschr; 2003 May 02; 128(18):999-1002. PubMed ID: 12721879
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
    Bell GK, Goldhaber SZ.
    Vasc Med; 2001 May 02; 6(1):23-9. PubMed ID: 11358156
    [Abstract] [Full Text] [Related]

  • 14. Prevention of thrombosis during pregnancy.
    Vilela VS, de Jesús NR, Levy RA.
    Isr Med Assoc J; 2002 Oct 02; 4(10):794-7. PubMed ID: 12389343
    [No Abstract] [Full Text] [Related]

  • 15. Current trends in the management of deep venous thrombosis and postthrombotic syndrome.
    Raju S, Neglen P.
    J Miss State Med Assoc; 2001 Feb 02; 42(2):35-41. PubMed ID: 11214388
    [No Abstract] [Full Text] [Related]

  • 16. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun 12; 145(24):56. PubMed ID: 12866309
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J, Riess H, Büller HR, Brom J, Weidinger G, Huisman MV.
    Haematologica; 2003 Oct 12; 88(10):1157-62. PubMed ID: 14555312
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of venous thromboembolism].
    Rocha E, Panizo C, Lecumberri R.
    Med Clin (Barc); 2000 Jul 08; 115(6):224-35. PubMed ID: 11002463
    [No Abstract] [Full Text] [Related]

  • 20. Best evidence topic report. Low molecular weight heparin for intravenous drug users with deep vein thrombosis.
    Russell M, Dawson D.
    Emerg Med J; 2004 Nov 08; 21(6):711. PubMed ID: 15496703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.